Background Malaria is an extremely devastating disease that continues to affect millions of
people each year. A distinctive attribute of malaria infected red blood cells is the presence of …

Atovaquone belongs to a naphthoquinone class of drugs and is used in combination with
proguanil (Malarone) for the treatment of acute, uncomplicated malaria caused by …

Adverse drug reactions (ADRs) are one of the major causes of morbidity and mortality
worldwide. It is well-known that individual genetic make-up is one of the causative factors of …

Multidrug-resistant Plasmodium falciparum parasites have emerged in Cambodia and
neighboring countries in Southeast Asia, compromising the efficacy of first-line antimalarial …

Background Artemisinin-based combination therapy (ACT) was deployed in 2005 as an
alternative to chloroquine and is considered the most efficacious treatment currently …

Malaria is known to cause around 1 million deaths per annum. This life-threatening disease
is mostly prevalent in Africa. Due to the burgeoning problem of drug resistance, it is getting …

The current decline in antimalarial drug efficacy due to the evolution of resistant Plasmodium
strains calls for new strategies capable of improving the bioavailability of antimalarials …

Emergence of drugs resistant strains of Plasmodium falciparum has augmented the scourge
of malaria in endemic areas. Antimalaria drugs act on different intracellular targets. The …

Background: Aqueous extracts of Tridax procumbens (TP)(Compositae) and Phyllanthus
amarus (PA)(Euphorbiaceae) are used in traditional medicine in Ghana to treat malaria …

Background. In response to international efforts to control and eradicate malaria, we
designed this study to give a bibliometric overview of research productivity in antimalarial …